Loading...
Derniers dépôts
-
Valerie Stoker, Paul Krack, Lisa Tonder, Gillian Barnett, Isabelle Durand-Zaleski, et al.. Deep Brain Stimulation Impact on Social and Occupational Functioning in Parkinson's Disease with Early Motor Complications. Movement Disorders Clinical Practice, 2020, 7 (6), pp.672-680. ⟨10.1002/mdc3.13015⟩. ⟨hal-04525172⟩
-
Alberto Benussi, Antonella Alberici, Kiran Samra, Lucy L Russell, Caroline V Greaves, et al.. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2021, 18 (7), pp.1408-1423. ⟨10.1002/alz.12485⟩. ⟨hal-04525009⟩
-
Olin Janssen, Willemijn J Jansen, Stephanie Vos, Merce Boada, Lucilla Parnetti, et al.. Characteristics of subjective cognitive decline associated with amyloid positivity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2021, 18 (10), pp.1832-1845. ⟨10.1002/alz.12512⟩. ⟨hal-04524946⟩
-
Mohammed H Ahmed, Isaias Hernández-Verdin, Emie Quissac, Nolwenn Lemaire, Coralie Guerin, et al.. Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model. Pharmaceutics, 2023, 15 (2), pp.455. ⟨10.3390/pharmaceutics15020455⟩. ⟨hal-04523991⟩
-
Hans-Jürgen Kreienkamp, Matias Wagner, Heike Weigand, Allyn Mcconkie-Rossell, Marie Mcdonald, et al.. Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males. Human Genetics, 2021, 141 (2), pp.257-272. ⟨10.1007/s00439-021-02412-x⟩. ⟨hal-04522950⟩
-
Andrea I Luppi, Joana Cabral, Rodrigo Cofre, Pedro A.M. Mediano, Fernando E Rosas, et al.. Computational modelling in disorders of consciousness: Closing the gap towards personalised models for restoring consciousness. NeuroImage, 2023, 275, pp.120162. ⟨10.1016/j.neuroimage.2023.120162⟩. ⟨hal-04522925⟩
-
Justin T Jordan, Christina C Orr, Raquel D Thalheimer, Josephine V Cambillo, Roberta L Beauchamp, et al.. Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. Neuro-Oncology Advances, 2023, 5 (1), pp.vdad041. ⟨10.1093/noajnl/vdad041⟩. ⟨hal-04522875⟩
-
Benoit Souchet, Alkéos Michaïl, Maud Heuillet, Aude Dupuy‐gayral, Eloi Haudebourg, et al.. Multiomics Blood Biomarkers Predict Alzheimer from predementia with High Specificity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2023, 19 (S24), pp.e082707. ⟨10.1002/alz.082707⟩. ⟨hal-04522821⟩